Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences

About this update from Gilead Sciences, Inc.

FOSTER CITY, Calif., May 01, 2026 --( BUSINESS WIRE )--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: The live webcasts can be accessed at the company’s investors page at investors.gilead.com . The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000. View source version on businesswire.com: https://www.businesswire.com/news/home/20260501262300/en/ Contacts Jacquie Ross, CFA – Investors [email protected]

View stock analysis, news, and events for Gilead Sciences, Inc.